Slater supports biopharma and biotech companies in their business development and commercialization strategy. He partners with companies focused on commercial assessments, business development and new product planning strategy, pipeline/portfolio prioritization and strategy, and launch roadmap planning, bringing deep experience in rare diseases. Clients leverage Slater’s insights in navigating early- to mid- clinical stage product development opportunities and the commercial needs required to recognize their full potential.
Prior to joining ClearView, Slater spent several years working in a translational hematology/oncology research lab in the Boston area. Slater holds a B.A. from Duke University and a M.S. from Boston University.
Debbi Amanti Belanger